glp 1 and glp 2 GLP-1 Receptor Agonists as Treatments for Type Diabetes GLP-1 and Inflammation: How These
Description
Originally developed for type 2 diabetes, clinicians quickly recognized their powerful impact on weight loss
7477 Failure to include this information in our algorithm could create hesitancy to intervene to effectively manage existing overweight or obesity in people living with SMI
In medically suitable patients with type 2 diabetes, this helps support glucose-dependent insulin release, reduces inappropriate glucagon release, and improves overall blood-glucose and HbA1c control
Iwaya, C., Nomiyama, T., Komatsu, S., Kawanami, T., Tsutsumi, Y., Hamaguchi, Y., Horikawa, T., Yoshinaga, Y., Yamashita, S., Tanaka, T., et al
1 October 2015
No Subscription
